Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Avanos Medical (AVNS) Operating Expenses (2016 - 2025)

Avanos Medical (AVNS) has disclosed Operating Expenses for 13 consecutive years, with $84.9 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses fell 0.59% to $84.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $338.9 million through Dec 2025, down 1.68% year-over-year, with the annual reading at $338.9 million for FY2025, 1.68% down from the prior year.
  • Operating Expenses hit $84.9 million in Q4 2025 for Avanos Medical, up from $83.6 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $99.8 million in Q2 2023 to a low of $66.1 million in Q4 2021.
  • Historically, Operating Expenses has averaged $86.1 million across 5 years, with a median of $85.1 million in 2022.
  • Biggest five-year swings in Operating Expenses: dropped 28.0% in 2021 and later rose 29.95% in 2022.
  • Year by year, Operating Expenses stood at $66.1 million in 2021, then grew by 29.95% to $85.9 million in 2022, then dropped by 5.36% to $81.3 million in 2023, then rose by 5.04% to $85.4 million in 2024, then fell by 0.59% to $84.9 million in 2025.
  • Business Quant data shows Operating Expenses for AVNS at $84.9 million in Q4 2025, $83.6 million in Q3 2025, and $89.3 million in Q2 2025.